Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea

被引：3
|
作者：
Petty, Amy J. [1 ]
Emge, Drew A. [1 ]
Blanchard, Sarah K. [1 ]
Selim, Maria Angelica [2 ]
Scoggins, Kim [1 ]
Liu, Beiyu [3 ]
Green, Cynthia L. [3 ]
Cardones, Adela R. [4 ,5 ]
机构：
[1] Duke Univ, Dept Dermatol, Durham, NC USA
[2] Duke Univ, Dept Pathol, Div Dermatopathol, Durham, NC USA
[3] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[4] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, Kansas City, KS USA
[5] Univ Kansas, Med Ctr, Dept Internal Med, Div Dermatol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 02期
关键词：
clinical trial; crisaborole; fibrosis; morphea; PDE4; CHILDREN; SAFETY;
D O I：
10.1016/j.jaad.2023.03.052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：390 / 392
页数：3
相关论文
共 50 条
  • [31] Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial
    Suichi, Tomoki
    Misawa, Sonoko
    Nagashima, Kengo
    Sato, Yasunori
    Iwai, Yuta
    Katayama, Kanako
    Sekiguchi, Yukari
    Shibuya, Kazumoto
    Amino, Hiroshi
    Suzuki, Yo-Ichi
    Tsuneyama, Atsuko
    Nakamura, Keigo
    Kuwabara, Satoshi
    INTERNAL MEDICINE, 2020, 59 (09) : 1149 - 1153
  • [32] BendamustinetreatmentofChinesepatientswithrelapsedindolentnon-Hodgkinlymphoma:amulticenter,open-label,single-arm,phase3study
    Shi Yuan-Kai
    Hong Xiao-Nan
    Yang Jian-Liang
    Xu Wei
    Huang Hui-Qiang
    Xiao Xiu-Bin
    Zhu Jun
    Zhou Dao-Bin
    Han Xiao-Hong
    Wu Jian-Qiu
    Zhang Ming-Zhi
    Jin Jie
    Ke Xiao-Yan
    Li Wei
    Wu De-Pei
    Yang Shen-Miao
    Du Xin
    Jia Yong-Qian
    Liu Ai-Chun
    Liu Dai-Hong
    Shen Zhi-Xiang
    Zhang Lian-Sheng
    James Leonard
    Hellriegel Edward
    中华医学杂志英文版, 2021, 134 (11) : 1299 - 1309
  • [33] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Matsueda, Kei
    Fukudo, Shin
    Ogishima, Masayuki
    Naito, Yuki
    Nakamura, Soichiro
    BIOPSYCHOSOCIAL MEDICINE, 2024, 18 (01)
  • [34] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Kei Matsueda
    Shin Fukudo
    Masayuki Ogishima
    Yuki Naito
    Soichiro Nakamura
    BioPsychoSocial Medicine, 18
  • [35] Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study
    Ma, Xinran
    Li, Ling
    Zhang, Lei
    Fu, Xiaorui
    Li, Xin
    Wang, Xinhua
    Wu, Jingjing
    Sun, Zhenchang
    Zhang, Xudong
    Feng, Xiaoyan
    Chang, Yu
    Zhou, Zhiyuan
    Nan, Feifei
    Zhang, Jieming
    Li, Zhaoming
    Zhang, Mingzhi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 275 - 284
  • [36] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [37] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
    O'Brien, Maureen M.
    Alonzo, Todd A.
    Cooper, Todd M.
    Levine, John E.
    Brown, Patrick A.
    Slone, Tamra
    August, Keith J.
    Benettaib, Bouchra
    Biserna, Noha
    Poon, Jennifer
    Patturajan, Meera
    Chen, Nianhang
    Simcock, Mathew
    Zimmerman, Linda
    Kolb, E. Anders
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [38] Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults
    Paradis, Erin M.
    Tikhonov, Oleg
    Cao, Xin
    Kharit, Susanna M.
    Fokin, Aleksandr
    Platt, Heather L.
    Banniettis, Natalie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4177 - 4182
  • [39] Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial
    Gao, Yanhang
    Kong, Fei
    Li, Guangming
    Li, Cheng
    Zheng, Sujun
    Lin, Jianmei
    Wen, Xiaofeng
    Hu, Jinghua
    Wang, Xiaozhong
    Wu, Xiaofeng
    Xing, Huichun
    Jia, Jidong
    Jia, Zhansheng
    Guan, Yujuan
    Li, Chenghao
    Wu, Guicheng
    Gao, Zhiliang
    Mou, Zhuangbo
    Ning, Qin
    Mao, Qing
    Yang, Yongfeng
    Ning, Jing
    Li, Li
    Pan, Hai
    Zhou, Desheng
    Ding, Yanhua
    Qin, Hong
    Niu, Junqi
    LIVER INTERNATIONAL, 2020, 40 (11) : 2685 - 2693
  • [40] Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
    Migden, Michael R.
    Khushalani, Nikhil I.
    Chang, Anne Lynn S.
    Lewis, Karl D.
    Schmults, Chrysalyne D.
    Hernandez-Aya, Leonel
    Meier, Friedegund
    Schadendorf, Dirk
    Guminski, Alexander
    Hauschild, Axel
    Wong, Deborah J.
    Daniels, Gregory A.
    Berking, Carola
    Jankovic, Vladimir
    Stankevich, Elizabeth
    Booth, Jocelyn
    Li, Siyu
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Fury, Matthew G.
    Rischin, Danny
    LANCET ONCOLOGY, 2020, 21 (02) : 294 - 305
12345